Brief: New JAZZ Band FDA clearance expands posterior fixation
23/09/2015 16:54
Sept 23 (Reuters) - Implanet SA IMPL.PA :
* Announces that it has received 510(k) regulatory clearance
from the Food & Drug Administration (FDA) in the United States
removing the intended the use of the JAZZ Band platform with the
Implanet Spine System
* Says JAZZ may be used with other posterior thoraco-lumbar
fixation systems (screws, rods, hooks) available on the market
Source text: http://bit.ly/1KzYys6
Further company coverage: IMPL.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 6983920;))